Integrative Physiology |
From the Departments of Pathology (J.W.F., M.G.K., S.L., T.N.W.) and Vascular Surgery (J.W.F., M.M.C., A.W.C.), University of Washington, Seattle.
Correspondence to Thomas N. Wight, PhD, Department of Pathology, HSB-Room 507, Box 357470, 1959 NE Pacific St, Seattle, WA 98195-7470. E-mail tnw{at}u.washington.edu
AbstractDecorin is an extracellular matrix (ECM) proteoglycan that may modify vascular smooth muscle cell (SMC) function by altering the response to growth factors and the accumulation of ECM proteins during vascular injury. To investigate these possibilities in vivo, decorin was overexpressed at the site of arterial injury by cell-mediated gene transfer. Fischer rat SMCs were transduced in vitro with a retroviral construct that contained the bovine decorin gene and were subsequently seeded into injured rat carotid arteries. A species-specific antibody to bovine decorin and polymerase chain reaction primers were used to detect bovine decorin and distinguish it from endogenous rat decorin. Immunohistochemical and Northern analyses of rat carotid arteries revealed only low levels of rat decorin expression up to 8 weeks after balloon injury. However, after cell-mediated transfer of bovine decorin, strong expression of bovine decorin was verified by immunohistochemistry and reverse transcriptasepolymerase chain reaction. Four weeks after injury, the intimal area in vessels seeded with bovine decorinoverexpressing SMCs was significantly reduced by 35±4% (mean±SEM, n=9; P<0.01). Decorin overexpression also induced a higher intimal nuclear density and decreased volume of ECM. Specifically, immunostaining for versican and fibronectin was markedly reduced. In contrast, immunostaining for collagen type I was increased, and electron microscopy confirmed that collagen accumulation was altered. Bromodeoxyuridine labeling indicated that intimal SMC proliferation was not affected by the expression of bovine decorin. In summary, we demonstrate that gene transfer of the ECM proteoglycan, decorin, into the injured arterial wall reduces intimal ECM volume and alters the composition of the ECM.
Key Words: proteoglycans smooth muscle cells extracellular matrix gene therapy hyperplasia
This article has been cited by other articles:
![]() |
K. Fu, M. J. Corbley, L. Sun, J. E. Friedman, F. Shan, J. L. Papadatos, D. Costa, F. Lutterodt, H. Sweigard, S. Bowes, et al. SM16, an Orally Active TGF-{beta} Type I Receptor Inhibitor Prevents Myofibroblast Induction and Vascular Fibrosis in the Rat Carotid Injury Model Arterioscler. Thromb. Vasc. Biol., April 1, 2008; 28(4): 665 - 671. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Fischer Tenascin-C: A key molecule in graft stenosis Cardiovasc Res, June 1, 2007; 74(3): 335 - 336. [Full Text] [PDF] |
||||
![]() |
R. Huang, M. J. Merrilees, K. Braun, B. Beaumont, J. Lemire, A. W. Clowes, A. Hinek, and T. N. Wight Inhibition of Versican Synthesis by Antisense Alters Smooth Muscle Cell Phenotype and Induces Elastic Fiber Formation In Vitro and in Neointima After Vessel Injury Circ. Res., February 17, 2006; 98(3): 370 - 377. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Spencer, S. L. Hacker, E. C. Davis, R. P. Mecham, R. H. Knutsen, D. Y. Li, R. D. Gerard, J. A. Richardson, E. N. Olson, and H. Yanagisawa Altered vascular remodeling in fibulin-5-deficient mice reveals a role of fibulin-5 in smooth muscle cell proliferation and migration PNAS, February 22, 2005; 102(8): 2946 - 2951. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Fischer, S. A. Steitz, P. Y. Johnson, A. Burke, F. Kolodgie, R. Virmani, C. Giachelli, and T. N. Wight Decorin Promotes Aortic Smooth Muscle Cell Calcification and Colocalizes to Calcified Regions in Human Atherosclerotic Lesions Arterioscler. Thromb. Vasc. Biol., December 1, 2004; 24(12): 2391 - 2396. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Farb, F. D. Kolodgie, J.-Y. Hwang, A. P. Burke, K. Tefera, D. K. Weber, T. N. Wight, and R. Virmani Extracellular Matrix Changes in Stented Human Coronary Arteries Circulation, August 24, 2004; 110(8): 940 - 947. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Shimizu-Hirota, H. Sasamura, M. Kuroda, E. Kobayashi, M. Hayashi, and T. Saruta Extracellular Matrix Glycoprotein Biglycan Enhances Vascular Smooth Muscle Cell Proliferation and Migration Circ. Res., April 30, 2004; 94(8): 1067 - 1074. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Jarvelainen, R. B. Vernon, M. D. Gooden, A. Francki, S. Lara, P. Y. Johnson, M. G. Kinsella, E. H. Sage, and T. N. Wight Overexpression of Decorin by Rat Arterial Smooth Muscle Cells Enhances Contraction of Type I Collagen In Vitro Arterioscler. Thromb. Vasc. Biol., January 1, 2004; 24(1): 67 - 72. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Nili, A. N. Cheema, F. J. Giordano, A. W. Barolet, S. Babaei, R. Hickey, M. R. Eskandarian, M. Smeets, J. Butany, G. Pasterkamp, et al. Decorin Inhibition of PDGF-Stimulated Vascular Smooth Muscle Cell Function: Potential Mechanism for Inhibition of Intimal Hyperplasia after Balloon Angioplasty Am. J. Pathol., September 1, 2003; 163(3): 869 - 878. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Merrilees, J. M. Lemire, J. W. Fischer, M. G. Kinsella, K. R. Braun, A. W. Clowes, and T. N. Wight Retrovirally Mediated Overexpression of Versican V3 by Arterial Smooth Muscle Cells Induces Tropoelastin Synthesis and Elastic Fiber Formation In Vitro and In Neointima After Vascular Injury Circ. Res., March 8, 2002; 90(4): 481 - 487. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kolb, P. J. Margetts, P. J. Sime, and J. Gauldie Proteoglycans decorin and biglycan differentially modulate TGF-{beta}-mediated fibrotic responses in the lung Am J Physiol Lung Cell Mol Physiol, June 1, 2001; 280(6): L1327 - L1334. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Fischer, M. G. Kinsella, B. Levkau, A. W. Clowes, and T. N. Wight Retroviral Overexpression of Decorin Differentially Affects the Response of Arterial Smooth Muscle Cells to Growth Factors Arterioscler. Thromb. Vasc. Biol., May 1, 2001; 21(5): 777 - 784. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. KOLB, P. J. MARGETTS, T. GALT, P. J. SIME, Z. XING, M. SCHMIDT, and J. GAULDIE Transient Transgene Expression of Decorin in the Lung Reduces the Fibrotic Response to Bleomycin Am. J. Respir. Crit. Care Med., March 1, 2001; 163(3): 770 - 777. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. T. Kovanen and M. O. Pentikainen Secretory Group II Phospholipase A2 : A Newly Recognized Acute-Phase Reactant With a Role in Atherogenesis Circ. Res., March 31, 2000; 86(6): 610 - 612. [Full Text] [PDF] |
||||
![]() |
M. J. Merrilees, J. M. Lemire, J. W. Fischer, M. G. Kinsella, K. R. Braun, A. W. Clowes, and T. N. Wight Retrovirally Mediated Overexpression of Versican V3 by Arterial Smooth Muscle Cells Induces Tropoelastin Synthesis and Elastic Fiber Formation In Vitro and In Neointima After Vascular Injury Circ. Res., March 8, 2002; 90(4): 481 - 487. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2000 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |